Karie Runcie
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC (NCT06863311) | Karie Runcie | 2026-03-13 |
Track Karie Runcie automatically
Every clearance here is in the API, with alerts when new ones post.